Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
The current Corcept Therapeutics(CORT) stock price is $115.70, with a market capitalization of 12.45B. The stock trades at a price-to-earnings (P/E) ratio of 274.04.
On 2026-10-01, Corcept Therapeutics(CORT) stock moved within a range of $113.98 to $118.07. With shares now at $115.70, the stock is trading +1.5% above its intraday low and -2.0% below the session's peak.
Trading activity shows a volume of 907.96K, compared to an average daily volume of 2.59M.
Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $126.38 and a low of $28.66.
Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $126.38 and a low of $28.66.
CORT News
Corcept Therapeutics (CORT) announced an update on their ongoing clinical study. Corcept Therapeutics is running a Phase 1 study called “A Phase 1, Open-Label...
...
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.